Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells

Saraiva, 2010, The regulation of IL-10 production by immune cells, Nat Rev Immunol, 10, 170, 10.1038/nri2711 de Waal Malefyt, 1991, Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J Exp Med, 174, 1209, 10.1084/jem.174.5.1209 Fiorentino, 1991, IL-10 inhibits cytokine production by activated macrophages, J Immunol, 147, 3815, 10.4049/jimmunol.147.11.3815 Taga, 1993, Human interleukin-10 can directly inhibit T-cell growth, Blood, 81, 2964, 10.1182/blood.V81.11.2964.bloodjournal81112964 de Waal Malefyt, 1993, Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation, J Immunol, 150, 4754, 10.4049/jimmunol.150.11.4754 Jinquan, 2000, CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10, Immunology, 99, 402, 10.1046/j.1365-2567.2000.00954.x Groux, 1996, Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells, J Exp Med, 184, 19, 10.1084/jem.184.1.19 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Roncarolo, 2006, Interleukin-10-secreting type 1 regulatory T cells in rodents and humans, Immunol Rev, 212, 28, 10.1111/j.0105-2896.2006.00420.x Roncarolo, 1988, Antigen recognition by MHC-incompatible cells of a human mismatched chimera, J Exp Med, 168, 2139, 10.1084/jem.168.6.2139 Bacchetta, 1994, High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells, J Exp Med, 179, 493, 10.1084/jem.179.2.493 Serafini, 2009, Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia, Haematologica, 94, 1415, 10.3324/haematol.2008.003129 Bacchetta, 2002, Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines, Eur J Immunol, 32, 2237, 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2 Magnani, 2011, Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells, Eur J Immunol, 41, 1652, 10.1002/eji.201041120 Di Ianni, 2011, Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, 117, 3921, 10.1182/blood-2010-10-311894 Brunstein, 2011, Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics, Blood, 117, 1061, 10.1182/blood-2010-07-293795 Bacchetta, 2009, Interleukin-10 anergized donor T cell infusion improves immune reconstitution without severe graft-versus-host disease after haploidentical hematopoietic stem cell transplantation, Blood, 114, 45, 10.1182/blood.V114.22.45.45 Levings, 2001, IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells, J Immunol, 166, 5530, 10.4049/jimmunol.166.9.5530 Barrat, 2002, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines, J Exp Med, 195, 603, 10.1084/jem.20011629 Kemper, 2003, Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, 421, 388, 10.1038/nature01315 Pot, 2009, Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells, J Immunol, 183, 797, 10.4049/jimmunol.0901233 Levings, 2005, Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells, Blood, 105, 1162, 10.1182/blood-2004-03-1211 Bacchetta, 2010, Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy, Haematologica, 95, 2134, 10.3324/haematol.2010.025825 Gregori, 2010, Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway, Blood, 116, 935, 10.1182/blood-2009-07-234872 Ito, 2007, Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand, J Exp Med, 204, 105, 10.1084/jem.20061660 Brandt, 2005, Allo-specific T-cells encoding for viral IL-10 exert strong immunomodulatory effects in vitro but fail to prevent graft rejection, Am J Transplant, 5, 268, 10.1111/j.1600-6143.2005.00689.x Setoguchi, 2000, Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen, J Immunol, 165, 5980, 10.4049/jimmunol.165.10.5980 Guichelaar, 2008, Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response, J Immunol, 180, 1373, 10.4049/jimmunol.180.3.1373 Van Montfrans, 2002, Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model, Gastroenterology, 123, 1865, 10.1053/gast.2002.37067 Oh, 2002, CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation, J Allergy Clin Immunol, 110, 460, 10.1067/mai.2002.127512 Zhao, 2005, Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection, Gene Ther, 12, 1509, 10.1038/sj.gt.3302547 Trittibach, 2008, Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis, Gene Ther, 15, 1478, 10.1038/gt.2008.109 Cavalieri, 2003, Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence, Blood, 102, 497, 10.1182/blood-2003-01-0297 Marktel, 2003, Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation, Blood, 101, 1290, 10.1182/blood-2002-08-2351 Amendola, 2005, Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters, Nat Biotechnol, 23, 108, 10.1038/nbt1049 Akdis, 2004, Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J Exp Med, 199, 1567, 10.1084/jem.20032058 Häringer, 2009, Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood, J Exp Med, 206, 1009, 10.1084/jem.20082238 Bondanza, 2006, Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes, Blood, 107, 1828, 10.1182/blood-2005-09-3716 Misaki, 2000, [Antigen-specific T cells transduced with interleukin-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen], Nihon Rinsho Meneki Gakkai Kaishi, 23, 538, 10.2177/jsci.23.538 Bonini, 2007, The suicide gene therapy challenge: how to improve a successful gene therapy approach, Mol Ther, 15, 1248, 10.1038/sj.mt.6300190 Montini, 2006, Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration, Nat Biotechnol, 24, 687, 10.1038/nbt1216 Frauwirth, 2004, Regulation of T lymphocyte metabolism, J Immunol, 172, 4661, 10.4049/jimmunol.172.8.4661 Battaglia, 2006, Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance, Diabetes, 55, 40, 10.2337/diabetes.55.01.06.db05-0613 Brooks, 2006, Interleukin-10 determines viral clearance or persistence in vivo, Nat Med, 12, 1301, 10.1038/nm1492 Ejrnaes, 2006, Resolution of a chronic viral infection after interleukin-10 receptor blockade, J Exp Med, 203, 2461, 10.1084/jem.20061462 McMurchy, 2011, Moving to tolerance: clinical application of T regulatory cells, Semin Immunol, 23, 304, 10.1016/j.smim.2011.04.001 Ciceri, 2009, Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study, Lancet Oncol, 10, 489, 10.1016/S1470-2045(09)70074-9 De Palma, 2002, Transduction of a gene expression cassette using advanced generation lentiviral vectors, Meth Enzymol, 346, 514, 10.1016/S0076-6879(02)46074-0 Gentner, 2009, Stable knockdown of microRNA in vivo by lentiviral vectors, Nat Methods, 6, 63, 10.1038/nmeth.1277 Tanaka, 1993, Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice, J Exp Med, 178, 1103, 10.1084/jem.178.3.1103